News

Article

CPAN Year in Review 2023

CPAN Year in Review

In 2023, COA’s Patient Advocacy Network (CPAN) provided advocacy, education, and engagement opportunities in multiple ways. Key outcomes included 14 live advocacy events at community oncology practices including new CPAN chapter launches in Nevada, Ohio, and South Carolina. CPAN advocates and leadership stories were featured in multiple media publications, websites, social media, and COA’s Faces of Community Oncology campaign.

Click here to view CPAN’s Advocacy Year in Review.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of woman with text.
Image of man with text.
Ojjaara helps patients with myelofibrosis by reducing spleen size, easing symptoms, and improving anemia to boost independence from blood transfusions.
Image of Dr. Zhaoming Wang with text.
Enabling patients to generate CAR T-cells internally could cut kidney cancer therapy costs, explained Dr. Wayne Marasco of Dana-Farber Cancer Institute.
Image of woman with text.
Woman with text.
Q-TWiST may help patients with advanced kidney cancer and their doctors weigh treatment options by focusing on quality of life, not just disease control.
Kidney Cancer Research Embraces Biology-Driven Precision Approach
Related Content